Analyst Price Target is $12.50
▲ +163.71% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Achieve Life Sciences in the last 3 months. The average price target is $12.50, with a high forecast of $17.00 and a low forecast of $8.00. The average price target represents a 163.71% upside from the last price of $4.74.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Achieve Life Sciences. This Buy consensus rating has held steady for over two years.